Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

NuVasive To Expand Global Presence, Product Portfolio With Ellipse Buy

This article was originally published in The Gray Sheet

Executive Summary

NuVasive says Ellipse's magnetically adjustable implant systems will open new global markets, particularly in the pediatric space, and complement its current portfolio. Analysts say the move is positive, but at least one observer believes that NuVasive might have paid too much for the deal.


Related Content

NuVasive Settles With DOJ On Medicare Fraud Charges
Next Steps For NuVasive Following CEO Resignation


Related Companies

Related Deals




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst